[Ventricular tachyarrhythmia in acute and chronic myocardial ischemia: value of diagnostic procedures].
The analysis of the outcome of patients after myocardial infarction in general, as well as of studies to predict the outcome of asymptomatic post-myocardial infarction patients by non-invasive methods, leads to the following conclusions: 1) The incidence of ventricular fibrillation and mortality after acute myocardial infarction has been declining since the 1970s (2); the causes for this reduction are presumably multifactorial (thrombolysis of acute infarction, administration of ACE-inhibitors and increasing prescription of beta-blockers, improvement of intensive care medicine, rigorous correction of risk factors). 2) Development of ventricular tachycardia, electrocardiographically documented ventricular fibrillation or successful reanimation due to sudden circulatory arrest in clinical studies of post-myocardial infarction patients are endpoints which in future studies must be differentiated from each other. 3) In contrast to previous assumptions, the outcome of patients with primary ventricular fibrillation after acute myocardial infarction, that is, without preceding symptoms is guarded, so that such an event should prompt invasive diagnostic evaluation (coronary arteriography, programmed stimulation (?)). 4) Newer methods for risk stratification after myocardial infarction during the chronic phase, such as programmed stimulation, late potential analysis from the body surface as well as programmed ventricular stimulation appear to be superior to more conventional methods such as long-term ECG monitoring as well as exercise testing. It is recommended that all methods which determine the arrhythmogenic substrate are combined with a parameter of left ventricular ejection fraction because of the paramount importance of left ventricular pump function.(ABSTRACT TRUNCATED AT 250 WORDS)
Steinbeck
G
G
Medizinische Klinik I, Klinikum Grosshadern.
D001341:Autonomic Nervous System / Q000503:physiopathology; D016757:Death, Sudden, Cardiac / Q000209:etiology; D017147:Defibrillators, Implantable; D006329:Heart Conduction System / Q000503:physiopathology; D006439:Hemodynamics / Q000502:physiology; D006801:Humans; D009203:Myocardial Infarction / Q000175:diagnosis* / Q000401:mortality / Q000503:physiopathology; D017202:Myocardial Ischemia / Q000175:diagnosis* / Q000401:mortality / Q000503:physiopathology; D012307:Risk Factors; D015996:Survival Rate; D017180:Tachycardia, Ventricular / Q000175:diagnosis* / Q000401:mortality / Q000503:physiopathology; D014693:Ventricular Fibrillation / Q000175:diagnosis* / Q000401:mortality / Q000503:physiopathology; D016277:Ventricular Function, Left / Q000502:physiology
Ventrikuläre Tachyarrhythmie bei akuter und chronischer Myokardischämie: Wertigkeit diagnostischer Verfahren.